EUVIMEDEUVIMED entdecken
Crossref

Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome

Rifaat R Rawashdeh, Holly Pederson iD, Rafal Iskanderian iD, Fawad Khan, Basel Altrabulsi, Stephanie Ricci, Charis Eng, Bassel Jallad, Asma Ibrahim Al Mannaei, Mohamed Salem Alameri iD, Azza Attia, Stephen R Grobmyer iD

JCO Global Oncology · 2024

DOI: 10.1200/go-24-00352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2024. Verfasst von Rifaat R Rawashdeh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Genetic Testing, Germ-Line Mutation, Hereditary Breast and Ovarian Cancer Syndrome, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Breast cancer among Emirati patients is characterized by early-onset disease and later stages at presentation. Little is known about the germline genetic variants that may contribute to these observations. The goal of this study is to characterize the rate and implications of germline genetic variants among a cohort of Emirati patients at risk for hereditary breast and ovarian cancer syndrome. MATERIALS AND METHODS A retrospective study was performed to analyze the results of clinical germline genetic testing (March 2020-January 2023) among a cohort of consecutive Emirati patients at risk for hereditary breast and ovarian cancer syndrome: group A: patients with personal history of breast or ovarian cancer (n = 135); group B: unaffected patients with family history of breast or ovarian cancer (n = 37); and group C: patients presenting for cascade testing (n = 20). Management of patients identified to have pathogenic/likely pathogenic (P/LP) variants was analyzed. RESULTS The rate of P/LP germline variants for each group was: group A: 17.3%, group B: 16.6%, group C: 57.9%. BRCA1 gene was the most commonly identified gene harboring P/LP variants, followed by BRCA2 , among this cohort. Four unrelated patients had a recurrent BRCA1 pathogenic variant: c.4065_4068del (p.Asn1355Lysfs*10). Only two patients in this series elected risk-reducing mastectomy and four patients elected risk-reducing bilateral salpingo-oophorectomy. CONCLUSION A higher rate of P/LP variants is seen among Emirati patients at risk for hereditary breast and ovarian cancer syndrome compared with reports of similar patients from Western populations. Efforts to increase utilization and awareness of germline genetic testing are warranted among Emirati patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingGerm-Line MutationHereditary Breast and Ovarian Cancer SyndromeGenetic Predisposition to DiseaseHumansFemaleRetrospective StudiesUnited Arab EmiratesAdultMiddle AgedOvarian NeoplasmsBRCA1 ProteinYoung AdultAgedBreast NeoplasmsBRCA2 Protein

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 Protein

Autor:innen und Institutionen

  • Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Genomic Medicine Institute and Center for Personalized Genetic Healthcare, Cleveland Clinic Main Campus, Cleveland, OH.
  • Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Department of Health, Abu Dhabi, United Arab Emirates.
  • Clinical Genomics, M42, Abu Dhabi, United Arab Emirates.

ORCID-Profile: Holly Pederson, Rafal Iskanderian, Mohamed Salem Alameri, Stephen R Grobmyer

Zitieren

APA

Rawashdeh, R. R., Pederson, H., Iskanderian, R., Khan, F., Altrabulsi, B., Ricci, S., Eng, C., Jallad, B., Al Mannaei, A. I., Alameri, M. S., Attia, A., & Grobmyer, S. R. (2024). Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO Global Oncology. https://doi.org/10.1200/go-24-00352

Vancouver

Rawashdeh RR, Pederson H, Iskanderian R, Khan F, Altrabulsi B, Ricci S, et al. Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO Global Oncology. 2024. doi:10.1200/go-24-00352

BibTeX
@article{Rawashdeh2024,
  author = {Rawashdeh, Rifaat R and Pederson, Holly and Iskanderian, Rafal and Khan, Fawad and Altrabulsi, Basel and Ricci, Stephanie and Eng, Charis and Jallad, Bassel and Al Mannaei, Asma Ibrahim and Alameri, Mohamed Salem and Attia, Azza and Grobmyer, Stephen R},
  title = {Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome},
  journal = {JCO Global Oncology},
  year = {2024},
  doi = {10.1200/go-24-00352}
}
Kostenlos starten →